| Market Cap | ₹953Cr |
| ROE | 28.46% |
| P/E Ratio(TTM) | 11.22 |
| EPS(TTM) | 28.87 |
| P/B Ratio | 2.44 |
| Dividend Yield | 0.76% |
| Industry P/E | 31.55 |
| Book Value | 132.83 |
| Debt to Equity | 0.29 |
| Face Value | 5 |
| Managing Director | Prashant Nagre |
| Founded | 1951 |
| BSE Symbol | 506414 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 65.90 | ||
| Neuland Laboratories | NA (0.00%) | 94.84 | ||
| Acutaas Chemicals | NA (0.00%) | 57.09 | ||
| Jubilant Pharmova | NA (0.00%) | 33.25 |